Siah1 proteins enhance radiosensitivity of human breast cancer cells

Hai-Tao He1, Emmanouil Fokas, An You

  • 1Department of Radiotherapy and Radiation Oncology, Philipps-University Marburg, Baldingerstr, D-35043 Marburg, Germany.

BMC Cancer
|August 5, 2010
PubMed
Abstract

Insights

Overexpression of Siah1 and Siah1L enhances breast cancer cell radiosensitivity by increasing apoptosis and inhibiting DNA repair. This suggests Siah1 and Siah1L augmenting drugs could improve tumor cell kill.

Area of Science:

  • Oncology
  • Molecular Biology
  • Radiotherapy

Background:

  • Siah proteins are implicated in cancer progression.
  • The role of Siah1 and its splice variants in breast cancer radiosensitization requires further investigation.

Purpose of the Study:

  • To evaluate the effect of Siah1, Siah1L, and Siah1DeltaR on the radiosensitization of human breast cancer cells.
  • To assess the impact of Siah1 overexpression and silencing on cellular processes including apoptosis, proliferation, survival, invasion, and DNA repair in the context of radiation therapy.

Main Methods:

  • Analysis of Siah1 and Siah1L mRNA expression in five breast cancer cell lines.
  • Stable transfection of SKBR3 cells with Siah1, Siah-1L, and Siah1DeltaR.
  • Siah1 function suppression using siRNA in MCF-7 cells.
  • Assessment of apoptosis, proliferation, survival, invasion, and DNA repair in response to radiation following Siah1 manipulation.

Main Results:

  • Siah1 and Siah1L mRNA were absent in most cell lines analyzed.
  • Overexpression of Siah1 and Siah1L enhanced radiation-induced apoptosis and reduced clonogenic survival and proliferation in SKBR3 cells.
  • Siah1 and Siah1L overexpression inhibited DNA repair, evidenced by increased DNA double-strand breaks.
  • Siah1 siRNA showed opposite effects in MCF-7 cells, and Siah1/Siah1L reduced invasion ability and Tcf/Lef activity.

Conclusions:

  • Siah1 and Siah1L overexpression significantly influence breast cancer cell radiosensitivity.
  • Targeting Siah1 and Siah1L activity presents a potential therapeutic strategy for enhancing tumor cell kill in cancer treatment.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...